Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1335-1341

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rainwater, D. L.
Right arrow Articles by Haffner, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rainwater, D. L.
Right arrow Articles by Haffner, S. M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1335-1341.)
© 1998 American Heart Association, Inc.


Original Contributions

Insulin and 2-Hour Glucose Levels Are Inversely Related to Lp(a) Concentrations Controlled for LPA Genotype

David L. Rainwater; ; Steven M. Haffner

From the Department of Genetics, Southwest Foundation for Biomedical Research (D.L.R.), and the Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center (S.M.H.), San Antonio, Tex.

Correspondence to David L. Rainwater, PhD, Department of Genetics, PO Box 760549, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549. E-mail david{at}darwin.sfbr.org

Abstract—In this study we assessed the relationship of lipoprotein(a) [Lp(a)] with diabetes status and with measures of glucose and insulin in a population of Mexican Americans having a high prevalence of non–insulin-dependent diabetes mellitus (NIDDM). Because of enormous allelic diversity at LPA [the locus encoding the apo(a) protein] that directly influences Lp(a) concentrations, it was first necessary to adjust for the large effects of variation at LPA. We calculated residual Lp(a) concentration as the difference between observed and expected; expected Lp(a) concentration was based on information from all family members sharing each identical-by-descent (IBD) allele. We found significant effects of sex and age on residual Lp(a) concentrations that increased with age (P=0.0004) and in females (P=0.0034). Although diabetes status per se was not related to residual Lp(a) concentrations (P=0.097), we found that residual Lp(a) concentrations were inversely correlated with fasting insulin (P=0.0017) and with insulin (P=0.0028) and glucose (P=0.0429) concentrations measured 2 hours after a glucose challenge. Furthermore, significant inverse correlations with the 2 insulin measures were observed for a subgroup of nondiabetic individuals. Inclusion of 2 lipid measures (plasma concentrations of cholesterol and triglycerides) in the models showed that the correlations with insulin and glucose were independent of the relationship between Lp(a) concentrations and the lipid measures. Also, we determined the residual size for each apo(a) isoform by adjusting for the IBD isoform group average. Although not related to diabetes status, residual apo(a) isoform size was positively correlated with fasting insulin (P=0.0013) and with 2-hour glucose (P=0.0246) and 2-hour insulin (P=0.0182) concentrations. In addition, significant correlations for all 4 measures were found for the subgroup of nondiabetic individuals. Thus, the results demonstrate that glucose-intolerant individuals have significantly lower residual Lp(a) concentrations and a significant increase of residual apo(a) size.


Key Words: non–insulin-dependent diabetes mellitus • glucose tolerance • Lp(a) • apo(a) genotypes • Mexican Americans




This article has been cited by other articles:


Home page
Arch Intern MedHome page
M. R. Sowers, J. Randolph Jr, M. Jannausch, B. Lasley, E. Jackson, and D. McConnell
Levels of Sex Steroid and Cardiovascular Disease Measures in Premenopausal and Hormone-Treated Women at Midlife: Implications for the "Timing Hypothesis"
Arch Intern Med, October 27, 2008; 168(19): 2146 - 2153.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Gazzaruso, A. Garzaniti, S. Giordanetti, C. Falcone, E. De Amici, D. Geroldi, and P. Fratino
Assessment of Asymptomatic Coronary Artery Disease in Apparently Uncomplicated Type 2 Diabetic Patients: A role for lipoprotein(a) and apolipoprotein(a) polymorphism
Diabetes Care, August 1, 2002; 25(8): 1418 - 1424.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Aguilar-Salinas, E. Reyes-RodrÍguez, Ma. L. Ordóñez-Sánchez, M. A. Torres, S. Ramírez-Jiménez, A. Domínguez-López, J. R. MartÍnez-Francois, Ma. L. Velasco-Pérez, M. Alpizar, E. GarcÍa-GarcÍa, et al.
Early-Onset Type 2 Diabetes: Metabolic and Genetic Characterization in the Mexican Population
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 220 - 226.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Rainwater, C. A. McMahan, G. T. Malcom, W. D. Scheer, P. S. Roheim, H. C. McGill Jr, and J. P. Strong
Lipid and Apolipoprotein Predictors of Atherosclerosis in Youth : Apolipoprotein Concentrations Do Not Materially Improve Prediction of Arterial Lesions in PDAY Subjects
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 753 - 761.
[Abstract] [Full Text] [PDF]